194 related articles for article (PubMed ID: 35960731)
1. Association between HLA-C alleles and COVID-19 severity in a pilot study with a Spanish Mediterranean Caucasian cohort.
Vigón L; Galán M; Torres M; Martín-Galiano AJ; Rodríguez-Mora S; Mateos E; Corona M; Malo R; Navarro C; Murciano-Antón MA; García-Gutiérrez V; Planelles V; Martínez-Laso J; López-Huertas MR; Coiras M;
PLoS One; 2022; 17(8):e0272867. PubMed ID: 35960731
[TBL] [Abstract][Full Text] [Related]
2. Possible role of HLA class-I genotype in SARS-CoV-2 infection and progression: A pilot study in a cohort of Covid-19 Spanish patients.
Iturrieta-Zuazo I; Rita CG; García-Soidán A; de Malet Pintos-Fonseca A; Alonso-Alarcón N; Pariente-Rodríguez R; Tejeda-Velarde A; Serrano-Villar S; Castañer-Alabau JL; Nieto-Gañán I
Clin Immunol; 2020 Oct; 219():108572. PubMed ID: 32810602
[TBL] [Abstract][Full Text] [Related]
3. HLA-C*04:01 Affects HLA Class I Heterozygosity and Predicted Affinity to SARS-CoV-2 Peptides, and in Combination With Age and Sex of Armenian Patients Contributes to COVID-19 Severity.
Hovhannisyan A; Madelian V; Avagyan S; Nazaretyan M; Hyussyan A; Sirunyan A; Arakelyan R; Manukyan Z; Yepiskoposyan L; Mayilyan KR; Jordan F
Front Immunol; 2022; 13():769900. PubMed ID: 35185875
[TBL] [Abstract][Full Text] [Related]
4. Natural killer-cell immunoglobulin-like receptors trigger differences in immune response to SARS-CoV-2 infection.
Littera R; Chessa L; Deidda S; Angioni G; Campagna M; Lai S; Melis M; Cipri S; Firinu D; Santus S; Lai A; Porcella R; Rassu S; Meloni F; Schirru D; Cordeddu W; Kowalik MA; Ragatzu P; Vacca M; Cannas F; Alba F; Carta MG; Del Giacco S; Restivo A; Deidda S; Palimodde A; Congera P; Perra R; Orrù G; Pes F; Loi M; Murru C; Urru E; Onali S; Coghe F; Giglio S; Perra A
PLoS One; 2021; 16(8):e0255608. PubMed ID: 34352002
[TBL] [Abstract][Full Text] [Related]
5. HLA-A*11:01 and HLA-C*04:01 are associated with severe COVID-19.
Castro-Santos P; Rojas-Martinez A; Riancho JA; Lapunzina P; Flores C; Carracedo Á; Díaz-Peña R;
HLA; 2023 Dec; 102(6):731-739. PubMed ID: 37528566
[TBL] [Abstract][Full Text] [Related]
6.
Naidoo L; Arumugam T; Ramsuran V
Genes (Basel); 2024 Apr; 15(4):. PubMed ID: 38674456
[TBL] [Abstract][Full Text] [Related]
7. The role of the HLA allelic repertoire on the clinical severity of COVID-19 in Canadians, living in the Saskatchewan province.
Kakodkar P; Dokouhaki P; Wu F; Shavadia J; Nair R; Webster D; Sawyer T; Huan T; Mostafa A
Hum Immunol; 2023 Mar; 84(3):163-171. PubMed ID: 36707385
[TBL] [Abstract][Full Text] [Related]
8. HLA class I associations with the severity of COVID-19 disease in the United Arab Emirates.
Tay GK; Alnaqbi H; Chehadeh S; Peramo B; Mustafa F; Rizvi TA; Mahboub BH; Uddin M; Alkaabi N; Alefishat E; Jelinek HF; Alsafar H;
PLoS One; 2023; 18(9):e0285712. PubMed ID: 37708194
[TBL] [Abstract][Full Text] [Related]
9. HLA-Bw4 in association with KIR3DL1 favors natural killer cell-mediated protection against severe COVID-19.
Wang R; Sun Y; Kuang BH; Yan X; Lei J; Lin YX; Tian J; Li Y; Xie X; Chen T; Zhang H; Zeng YX; Zhao J; Feng L
Emerg Microbes Infect; 2023 Dec; 12(1):2185467. PubMed ID: 36849422
[TBL] [Abstract][Full Text] [Related]
10. HLA Allele Frequencies and Association with Severity of COVID-19 Infection in Northern Italian Patients.
Guerini FR; Bolognesi E; Lax A; Bianchi LNC; Caronni A; Zanzottera M; Agliardi C; Albergoni MP; Banfi PI; Navarro J; Clerici M
Cells; 2022 May; 11(11):. PubMed ID: 35681490
[TBL] [Abstract][Full Text] [Related]
11. MHC Haplotyping of SARS-CoV-2 Patients: HLA Subtypes Are Not Associated with the Presence and Severity of COVID-19 in the Israeli Population.
Ben Shachar S; Barda N; Manor S; Israeli S; Dagan N; Carmi S; Balicer R; Zisser B; Louzoun Y
J Clin Immunol; 2021 Aug; 41(6):1154-1161. PubMed ID: 34050837
[TBL] [Abstract][Full Text] [Related]
12. Protective HLA alleles against severe COVID-19: HLA-A*68 as an ancestral protection allele in Tapachula-Chiapas, Mexico.
Hernández-Doño S; Sánchez-González RA; Trujillo-Vizuet MG; Zamudio-Castellanos FY; García-Silva R; Bulos-Rodríguez P; Vazquez-Guzmán CA; Cárdenas-Ramos X; de León Rodríguez D; Elías F; Domínguez-Arrevillaga S; Pérez-Tirado JM; Vera-Lastra OL; Granados J; Sepúlveda-Delgado J
Clin Immunol; 2022 May; 238():108990. PubMed ID: 35395388
[TBL] [Abstract][Full Text] [Related]
13. The KIR2DL2/HLA-C1C1 Gene Pairing Is Associated With an Increased Risk of SARS-CoV-2 Infection.
Hu S; Shao Z; Ni W; Sun P; Qiao J; Wan H; Huang Y; Liu X; Zhai H; Xiao M; Sun B
Front Immunol; 2022; 13():919110. PubMed ID: 35874712
[TBL] [Abstract][Full Text] [Related]
14. Association between the HLA genotype and the severity of COVID-19 infection among South Asians.
Naemi FMA; Al-Adwani S; Al-Khatabi H; Al-Nazawi A
J Med Virol; 2021 Jul; 93(7):4430-4437. PubMed ID: 33830530
[TBL] [Abstract][Full Text] [Related]
15. Stability and Expression Levels of HLA-C on the Cell Membrane Modulate HIV-1 Infectivity.
Parolini F; Biswas P; Serena M; Sironi F; Muraro V; Guizzardi E; Cazzoletti L; Scupoli MT; Gibellini D; Ugolotti E; Biassoni R; Beretta A; Malnati M; Romanelli MG; Zipeto D
J Virol; 2018 Jan; 92(1):. PubMed ID: 29070683
[TBL] [Abstract][Full Text] [Related]
16. HLA-A*11:01:01:01, HLA-C*12:02:02:01-HLA-B*52:01:02:02, Age and Sex Are Associated With Severity of Japanese COVID-19 With Respiratory Failure.
Khor SS; Omae Y; Nishida N; Sugiyama M; Kinoshita N; Suzuki T; Suzuki M; Suzuki S; Izumi S; Hojo M; Ohmagari N; Mizokami M; Tokunaga K
Front Immunol; 2021; 12():658570. PubMed ID: 33968060
[TBL] [Abstract][Full Text] [Related]
17. Association of HLA genotypes, AB0 blood type and chemokine receptor 5 mutant CD195 with the clinical course of COVID-19.
Fischer JC; Schmidt AG; Bölke E; Uhrberg M; Keitel V; Feldt T; Jensen B; Häussinger D; Adams O; Schneider EM; Balz V; Enczmann J; Rox J; Hermsen D; Schulze-Bosse K; Kindgen-Milles D; Knoefel WT; van Griensven M; Haussmann J; Tamaskovics B; Plettenberg C; Scheckenbach K; Corradini S; Pedoto A; Maas K; Schmidt L; Grebe O; Esposito I; Ehrhardt A; Peiper M; Buhren BA; Calles C; Stöhr A; Lichtenberg A; Freise NF; Lutterbeck M; Rezazadeh A; Budach W; Matuschek C
Eur J Med Res; 2021 Sep; 26(1):107. PubMed ID: 34530915
[TBL] [Abstract][Full Text] [Related]
18. Coronavirus-19 disease risk and protective factors associated with HLA/KIR polymorphisms in Ecuadorian patients residing in Madrid.
Balas A; Moreno-Hidalgo MÁ; de la Calle-Prieto F; Vicario JL; Arsuaga M; Trigo E; de Miguel-Buckley R; Bellón T; Díaz-Menéndez M
Hum Immunol; 2023 Nov; 84(11):571-577. PubMed ID: 37777360
[TBL] [Abstract][Full Text] [Related]
19. HLA-E*01:01 + HLA-E*01:01 genotype confers less susceptibility to COVID-19, while HLA-E*01:03 + HLA-E*01:03 genotype is associated with more severe disease.
Hosseini E; Minagar A; Ghasemzadeh M; Arabkhazaeli A; Ghasemzadeh A
Hum Immunol; 2023 Apr; 84(4):263-271. PubMed ID: 36822912
[TBL] [Abstract][Full Text] [Related]
20. The association of human leucocyte antigen (HLA) alleles with COVID-19 severity: A systematic review and meta-analysis.
Dobrijević Z; Gligorijević N; Šunderić M; Penezić A; Miljuš G; Tomić S; Nedić O
Rev Med Virol; 2023 Jan; 33(1):e2378. PubMed ID: 35818892
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
